...
首页> 外文期刊>Journal of Muscle Research and Cell Motility >Delineation of signalling pathway leading to antioxidant-dependent inhibition of dexamethasone-mediated muscle cell death
【24h】

Delineation of signalling pathway leading to antioxidant-dependent inhibition of dexamethasone-mediated muscle cell death

机译:信号通路的描绘导致抗氧化剂依赖性地塞米松介导的肌肉细胞死亡的抑制

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The molecular mechanism of the cell death-promoting effect of dexamethasone (Dex) was studied during myogenesis (10 days) in L6 muscle cells by making use of several indices such as cell viability (protein synthesis, mitochondrial respiration), mortality (DNA fragmentation, chromatin condensation, structural modifications) and immunocytochemical studies [hydrogen peroxide, m-calpain (calpain 2)]. Dex initially (2 nM) stimulated protein synthesis (P < 0.001), but a further increase (20 nM) did not stimulate, whereas a higher dose (200 nM) inhibited formation of cellular proteins (P < 0.001). The latter, apparently, resulted from impaired cell viability (P < 0.001). From the day 4, structural changes featuring cell death were observed. Antioxidants [sodium ascorbate (ASC), catalase (CAT) or N-acetyl-L-cysteine (NAC)] as well as the inhibition of transcription and translation by actinomycin D abrogated Dex-induced cell death (P < 0.001). Using a fluorescent probe (DCFH-DA) we directly corroborated the working hypothesis of the mediating role of H2O2 in the reduction of cell viability by the excess of glucocorticoids. We also found that tPKC, PLCγ, PLA2 were required to induce Dex-dependent cell death since inactivation of tPKC by H7 completely abolished the cytotoxic effect of Dex, while the blockade of PLCγ and PLA2 by U 73122 partially abolished the effect. Cell death was triggered by Ca2+ influx necessary to activate m-calpain since it was reversed by the calcium chelator EGTA or m-calpain inhibitor ALLN but not EDTA nor ALLM. However, cell viability impaired by Ca2+ ionophore A 23187 (P < 0.001) was neither reversed by EGTA, nor EDTA, nor caspase-3 blocker – Ac DEVD CHO, nor ALLN, nor antioxidants – ASC, NAC, CAT. Specific caspase-3 inhibitor Ac DEVD CHO also did not rescue cells from Dex-induced cell death (P < 0.001), in contrast to m-calpain inhibitor – ALLN. Taken together, these findings suggest that reactive oxygen species inhibit protein synthesis and amplify m-calpain-dependent proteolysis. The events that led to the death of L6 muscle cells most likely resulted from Dex-mediated repression of antioxidative defences on the genomic level.
机译:利用细胞活力(蛋白质合成,线粒体呼吸),死亡率(DNA断裂,DNA断裂,DNA断裂等)等多种指标研究了地塞米松(Dex)在L6肌肉细胞成肌(10天)期间促进细胞死亡的分子机制。染色质浓缩,结构修饰)和免疫细胞化学研究[过氧化氢,间钙蛋白酶(钙蛋白酶2)]。最初,Dex(2 nM)刺激了蛋白质的合成(P <0.001),但进一步的增加(20 nM)没有刺激,而更高的剂量(200 nM)则抑制了细胞蛋白质的形成(P <0.001)。后者显然是由于细胞活力受损引起的(P <0.001)。从第4天开始,观察到以细胞死亡为特征的结构变化。抗氧化剂[抗坏血酸钠(ASC),过氧化氢酶(CAT)或N-乙酰基-L-半胱氨酸(NAC)]以及放线菌素D抑制转录和翻译消除了Dex诱导的细胞死亡(P <0.001)。我们使用荧光探针(DCFH-DA)直接证实了H2 O2 介导的过量糖皮质激素降低细胞生存能力的介导作用的工作假设。我们还发现,由于H7使tPKC失活完全消除了Dex的细胞毒性作用,因此需要tPKC,PLCγ,PLA2 来诱导Dex依赖性细胞死亡,而由U 73122阻断PLCγ和PLA2 的细胞毒性作用。部分取消了效果。细胞死亡是由激活m-钙蛋白酶所必需的Ca2 +流入触发的,因为钙螯合剂EGTA或m-钙蛋白酶抑制剂ALLN可以逆转它,而不是EDTA或ALLM可以逆转它。但是,Ca2 +离子载体A 23187(P <0.001)损害的细胞活力既没有被EGTA也没有被EDTA逆转,也没有被caspase-3阻滞剂Ac DEVD CHO或ALLN逆转,也没有被抗氧化剂ASC,NAC,CAT逆转。与m-钙蛋白酶抑制剂ALLN相比,特定的caspase-3抑制剂Ac DEVD CHO也不能使细胞摆脱Dex诱导的细胞死亡(P <0.001)。综上所述,这些发现表明活性氧会抑制蛋白质合成并放大m-钙蛋白酶依赖性蛋白水解作用。导致L6肌肉细胞死亡的事件很可能是由于Dex介导的基因组水平上抗氧化防御的抑制。

著录项

  • 来源
  • 作者单位

    Department of Physiological Sciences Faculty of Veterinary Medicine Warsaw Agricultural University;

    Department of Physiological Sciences Faculty of Veterinary Medicine Warsaw Agricultural University;

    Laboratory of Cell Ultrastructure MRC Polish Academy of Sciences;

    Department of Physiological Sciences Faculty of Veterinary Medicine Warsaw Agricultural University;

    Department of Physiological Sciences Faculty of Veterinary Medicine Warsaw Agricultural University;

    Department of Physiological Sciences Faculty of Veterinary Medicine Warsaw Agricultural University;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号